+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Anti-malarial Medicines Market 2018-2022 - Product Image

Global Anti-malarial Medicines Market 2018-2022

  • ID: 4629673
  • Report
  • September 2018
  • Region: Global
  • 117 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Novartis
  • Pfizer
  • MORE
About Malaria

Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae.

The analysts forecast the Global Anti-malarial Medicines Market to grow at a CAGR of 4.76% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the anti-malarial medicines market. To calculate the market size, the report considers the revenue generated by sales of anti-malarial drugs across the globe.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, anti-malarial medicines market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Novartis
  • Pfizer
  • Sun Pharmaceutical Industries
Market drivers
  • Strong funding to eradicate malaria
  • For a full, detailed list, view the full report
Market challenges
  • Drug resistant pathogens
  • For a full, detailed list, view the full report
Market trends
  • Enhancement of POC diagnostics and biomarkers for malaria
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Novartis
  • Pfizer
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05: MARKET SIZING
  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07: PIPELINE

PART 08: MARKET SEGMENTATION BY PRODUCT
  • Segmentation by product
  • Comparison by product
  • Artemisinin compounds – Market size and forecast 2017-2022
  • Quinolines and related compounds – Market size and forecast 2017-2022
  • Other compounds – Market size and forecast 2017-2022
  • Market opportunity by product
PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Americas – Market size and forecast 2017-2022
  • EMEA – Market size and forecast 2017-2022
  • APAC – Market size and forecast 2017-2022
  • Market opportunity
PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 15: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Novartis
  • Pfizer
  • Sun Pharmaceutical Industries
PART 16: APPENDIX
  • List of abbreviations
List of Exhibits
Exhibit 01: Parent market
Exhibit 02: Global infectious disease medicines market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global anti-malarial medicines market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global anti-malarial medicines market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Pipeline landscape by development phase 2017-2018
Exhibit 19: Pipeline molecules for the treatment of malaria 2017-2018
Exhibit 20: Global anti-malarial medicines market by product – Market share 2017-2022 (%)
Exhibit 21: Comparison by product
Exhibit 22: Artemisinin compounds – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global anti-malarial medicines market by artemisinin compounds – Year-over-year growth 2018-2022 (%)
Exhibit 24: Global anti-malarial medicines market by quinolines and related compounds – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Global anti-malarial medicines market by quinolines and related compounds – Year-over-year growth 2018-2022 (%)
Exhibit 26: Global anti-malarial medicines market by other compounds – Market size and forecast 2017-2022 ($ mn)
Exhibit 27: Global anti-malarial medicines market by other compounds – Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Global anti-malarial medicines market by geography – Market share 2017-2022 (%)
Exhibit 31: Regional comparison
Exhibit 32: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 34: Top 3 countries in Americas
Exhibit 35: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 36: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 37: Top 3 countries in EMEA
Exhibit 38: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 39: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 40: Top 3 countries in APAC
Exhibit 41: Market opportunity
Exhibit 42: Percentage of people at risk of malaria worldwide
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: F. Hoffmann-La Roche: Overview
Exhibit 49: F. Hoffmann-La Roche – Business segments
Exhibit 50: F. Hoffmann-La Roche – Organizational developments
Exhibit 51: F. Hoffmann-La Roche – Geographic focus
Exhibit 52: F. Hoffmann-La Roche – Segment focus
Exhibit 53: F. Hoffmann-La Roche – Key offerings
Exhibit 54: F. Hoffmann-La Roche – Key customers
Exhibit 55: GlaxoSmithKline: Overview
Exhibit 56: GlaxoSmithKline – Business segments
Exhibit 57: GlaxoSmithKline – Organizational developments
Exhibit 58: GlaxoSmithKline – Geographic focus
Exhibit 59: GlaxoSmithKline – Segment focus
Exhibit 60: GlaxoSmithKline – Key offerings
Exhibit 61: GlaxoSmithKline – Key customers
Exhibit 62: Novartis: Overview
Exhibit 63: Novartis – Business segments
Exhibit 64: Novartis – Organizational developments
Exhibit 65: Novartis – Geographic focus
Exhibit 66: Novartis – Segment focus
Exhibit 67: Novartis – Key offerings
Exhibit 68: Novartis – Key customers
Exhibit 69: Pfizer: Overview
Exhibit 70: Pfizer – Business segments
Exhibit 71: Pfizer – Organizational developments
Exhibit 72: Pfizer – Geographic focus
Exhibit 73: Pfizer – Segment focus
Exhibit 74: Pfizer – Key offerings
Exhibit 75: Pfizer – Key customers
Exhibit 76: Sun Pharmaceutical Industries: Overview
Exhibit 77: Sun Pharmaceutical Industries – Business segments
Exhibit 78: Sun Pharmaceutical Industries – Organizational developments
Exhibit 79: Sun Pharmaceutical Industries – Geographic focus
Exhibit 80: Sun Pharmaceutical Industries – Segment focus
Exhibit 81: Sun Pharmaceutical Industries – Key offerings
Exhibit 82: Sun Pharmaceutical Industries – Key customers
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Novartis
  • Pfizer
  • MORE
Global Anti-malarial Medicines Market 2018-2022

The author of the report recognizes the following companies as the key players in the global anti-malarial medicines market: F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Pfizer, and Sun Pharmaceutical Industries.

Commenting on the report, an analyst from the research team said: “One trend affecting this market is the enhancement of POC diagnostics and biomarkers for malaria. The global anti-malarial medicines market has great potential for the use of innovative and better POC diagnostics for an effective control of malaria.”

According to the report, one driver influencing this market is the strong funding to eradicate malaria. Malaria is on the top of the eradication list of WHO and this is leading to strong funding initiatives for prevention and control of malaria.

Further, the report states that one challenge affecting this market are the drug resistant pathogens. Multidrug resistant microbes are a major threat as they can change themselves to protect themselves from antimicrobial agents and that is affecting the growth of the industry.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Novartis
  • Pfizer
  • Sun Pharmaceutical Industries
Note: Product cover images may vary from those shown
Adroll
adroll